XORTX Therapeutics Inc (XRTX)
XORTX Provides Corporate Update and Announces Appointment of Mika Grasso as Co-CEO
XORTX Provides Corporate Update and Announces Appointment of Mika Grasso as Co-CEO
Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe
Surge Copper Announces Results of Berg Pre-Feasibility Study with After-Tax NPV8% of C$4.6 billion and 24% IRR
VENU Plans $80 Million Sale-Leaseback Financing for Parking Garage Asset at Sunset Amphitheater in McKinney, Texas
IREN Completes Acquisition of Nostrum Group Expanding AI Cloud Platform to Europe
USA Rare Earth Commissions Hydrometallurgical Demonstration Facility, Targeting Heavy Rare Earth Oxide Production in Third Quarter 2026
HONEYWELL BOARD OF DIRECTORS APPROVES SPIN-OFF OF HONEYWELL AEROSPACE
Enhanced Group Announces $50 Million Strategic Financing Led by Enhanced Co-Founder and Chairman Christian Angermayer; Management Expects Company Fully Funded Through Profitability
Seer Board of Directors Issues Letter to Shareholders Highlighting the Company’s Significant Scientific Progress and Addressing Radoff and Torok’s Short-Sighted Campaign
OTC Markets Group Names Thomas Fasano Head of Broker-Dealer Sales